COMPANY PROFILE

MEDICANNX

MedicannX specializes in growing high-quality medical cannabis in Israel using advanced aeroponic cultivation techniques

Tirat Karmel, IsraelFounded 2020Biotech & Life Sciences

Valuation $100–250M Last recorded · 2024

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About MEDICANNX

MedicannX is a pioneering company in the medical cannabis industry, based in Israel, committed to producing premium-grade medical cannabis through cutting-edge aeroponic cultivation methods. Leveraging advanced technology, MedicannX utilizes a sophisticated aeroponic system that nurtures plants in a nutrient-rich mist environment, allowing for optimal growth conditions and higher yields. This innovative approach ensures superior quality and potency of cannabis, meeting the rigorous standards of the medical community. With a focus on research, development, and adherence to strict regulatory requirements, MedicannX aims to provide patients with safe, effective, and reliable medical cannabis solutions, contributing to advancements in therapeutic applications and enhancing patient care.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2020
Headquarters: Tirat Karmel, Israel
Employees: 7
Open positions: None listed
Dealroom signal: 76.5/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Alternative Medicine, Biotechnology, Cannabis, Biotech and Pharma, Medicinal Cannabis, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b, b2c
Links: Website LinkedIn

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
EARLY VC✓Equity / VC	Jul 2024	$18M	$74M	Darwin German Real Estate Investments	↗

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

MEDICANNX website traffic

Latest recorded traffic for MEDICANNX is 470 monthly website visits, up 20.5% over the last three months. MEDICANNX's team grew 0% over the past year.

Latest monthly visits470 3-month web change+20.5% 1-year team growth0%

Monthly website visitsJul 2024–Mar 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
POPortocannaMedical cannabis processor creating Europe's largest symbiotic ecosystem with GMP facilities and diverse distribution	Santarém, Portugal	Operational	46	—	—
EPEurox PharmaA company developing and manufacturing cannabis based medicines	Nideggen, Germany	Operational
TOTikun OlamTikun Olam Ltd breeds proprietary cannabis strains and develops standardized products with accurate dosage	Tel Aviv-Yafo, Israel	Operational
CACanaxCannabis extraction company for the development of CBD-based products for pharmaceutical and cosmectuical industry	Milan, Italy	Operational
SGSemdor Pharma GroupSpecializing in narcotics and medical cannabis, working with wholesalers, suppliers, and pharmacies	Cologne, Germany	Operational
ECElevate CBDManufacturing high-quality CBD products in the U.S. for both humans and pets	Telford, United States	Operational
XIXINTEZACannabinoid and Psychedelic Active Ingredients	Tel Aviv-Yafo, Israel	Operational
MEMediCropsHealth-tech firm specializing in medical cannabis distribution and digital patient care via telemedicine	Freienbach, Switzerland	Operational